Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter J Richardson

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Anti-Cancer Agents in Medicinal Chemistry|August 25, 2015
CXCR4 and GlioblastomaPeter J Richardson
Eclinicalmedicine|June 13, 2022
Baricitinib as the treatment of choice for hospitalised individuals with COVID-19Peter J Richardson, Justin Stebbing
The Lancet. Infectious Diseases|April 7, 2020
Baricitinib for COVID-19: a suitable treatment? - Authors' replyPeter J Richardson, Mario Corbellino, Justin Stebbing
Journal of Neurochemistry|June 18, 2002
Functional and molecular characterization of metabotropic glutamate receptors expressed in rat striatal cholinergic interneuronesMatt I Bell, Peter J Richardson, Kevin Lee
Neuroscience Letters|November 20, 2003
Adenosine modulates the striatal GABAergic inputs to the globus pallidus via adenosine A2A receptors in ratsTomomi Shindou, Peter J Richardson, Akihisa Mori, et al.
Vaccines|June 24, 2022
The AI-Assisted Identification and Clinical Efficacy of Baricitinib in the Treatment of COVID-19Peter J Richardson, Bruce W S Robinson, Daniel P Smith, et al.
British Journal of Pharmacology|May 16, 2002
Presynaptic adenosine A2A receptors enhance GABAergic synaptic transmission via a cyclic AMP dependent mechanism in the rat globus pallidusTomomi Shindou, Hiromi Nonaka, Peter J Richardson, et al.
Journal of Neurology|May 4, 2020
CNS penetration of potential anti-COVID-19 drugsPeter J Richardson, Silvia Ottaviani, Alessandro Prelle, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 8, 2005
Dual presynaptic control by ATP of glutamate release via facilitatory P2X1, P2X2/3, and P2X3 and inhibitory P2Y1, P2Y2, and/or P2Y4 receptors in the rat hippocampusRicardo J Rodrigues, Teresa Almeida, Peter J Richardson, et al.
Metabolism: Clinical and Experimental|December 6, 2005
Leptin-mediated inhibition of the insulin-stimulated increase in fatty acid uptake in differentiated 3T3-L1 adipocytesMichael Ho, Susan Foxall, Michael Higginbottom, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Anti-Cancer Agents in Medicinal Chemistry|August 25, 2015
CXCR4 and GlioblastomaPeter J Richardson
Eclinicalmedicine|June 13, 2022
Baricitinib as the treatment of choice for hospitalised individuals with COVID-19Peter J Richardson, Justin Stebbing
The Lancet. Infectious Diseases|April 7, 2020
Baricitinib for COVID-19: a suitable treatment? - Authors' replyPeter J Richardson, Mario Corbellino, Justin Stebbing
Journal of Neurochemistry|June 18, 2002
Functional and molecular characterization of metabotropic glutamate receptors expressed in rat striatal cholinergic interneuronesMatt I Bell, Peter J Richardson, Kevin Lee
Neuroscience Letters|November 20, 2003
Adenosine modulates the striatal GABAergic inputs to the globus pallidus via adenosine A2A receptors in ratsTomomi Shindou, Peter J Richardson, Akihisa Mori, et al.
Vaccines|June 24, 2022
The AI-Assisted Identification and Clinical Efficacy of Baricitinib in the Treatment of COVID-19Peter J Richardson, Bruce W S Robinson, Daniel P Smith, et al.
British Journal of Pharmacology|May 16, 2002
Presynaptic adenosine A2A receptors enhance GABAergic synaptic transmission via a cyclic AMP dependent mechanism in the rat globus pallidusTomomi Shindou, Hiromi Nonaka, Peter J Richardson, et al.
Journal of Neurology|May 4, 2020
CNS penetration of potential anti-COVID-19 drugsPeter J Richardson, Silvia Ottaviani, Alessandro Prelle, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 8, 2005
Dual presynaptic control by ATP of glutamate release via facilitatory P2X1, P2X2/3, and P2X3 and inhibitory P2Y1, P2Y2, and/or P2Y4 receptors in the rat hippocampusRicardo J Rodrigues, Teresa Almeida, Peter J Richardson, et al.
Metabolism: Clinical and Experimental|December 6, 2005
Leptin-mediated inhibition of the insulin-stimulated increase in fatty acid uptake in differentiated 3T3-L1 adipocytesMichael Ho, Susan Foxall, Michael Higginbottom, et al.
Pageof 2